Clinical Predictive Models for COVID-19: Systematic Study
  Coronavirus Disease 2019 (COVID-19) is a rapidly emerging respiratory disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due
to the rapid human-to-human transmission of SARS-CoV-2, many healthcare systems
are at risk of exceeding their healthcare capacities, in particular in terms of
SARS-CoV-2 tests, hospital and intensive care unit (ICU) beds and mechanical
ventilators. Predictive algorithms could potentially ease the strain on
healthcare systems by identifying those who are most likely to receive a
positive SARS-CoV-2 test, be hospitalised or admitted to the ICU. Here, we
study clinical predictive models that estimate, using machine learning and
based on routinely collected clinical data, which patients are likely to
receive a positive SARS-CoV-2 test, require hospitalisation or intensive care.
To evaluate the predictive performance of our models, we perform a
retrospective evaluation on clinical and blood analysis data from a cohort of
5644 patients. Our experimental results indicate that our predictive models
identify (i) patients that test positive for SARS-CoV-2 a priori at a
sensitivity of 75% (95% CI: 67%, 81%) and a specificity of 49% (95% CI: 46%,
51%), (ii) SARS-CoV-2 positive patients that require hospitalisation with 0.92
AUC (95% CI: 0.81, 0.98), and (iii) SARS-CoV-2 positive patients that require
critical care with 0.98 AUC (95% CI: 0.95, 1.00). In addition, we determine
which clinical features are predictive to what degree for each of the
aforementioned clinical tasks. Our results indicate that predictive models
trained on routinely collected clinical data could be used to predict clinical
pathways for COVID-19, and therefore help inform care and prioritise resources.
